Silk Road Medical announced that Chas McKhann has been appointed Chief Executive Officer, CEO, effective immediately. McKhann is an accomplished leader with more than 25 years of experience in the medical device industry, including C-suite positions at seven public and private companies. Most recently, McKhann served as President and CEO of Apollo Endosurgery.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SILK:
- Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023
- Silk Road Medical upgraded to Peer Perform from Underperform at Wolfe Research
- Silk Road Medical price target lowered to $8 from $28 at BofA
- Piper sees finalized NCD as net negative for Silk Road, positive for InspireMD
- Silk Road Medical downgraded to Neutral from Buy at CL King